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Editorial
The incidence of intra-operative awareness in the UK: under the
rate or under the radar?
Accidental awareness during
intended general anaesthesia with
postoperative explicit recall (AWR)
can be a devastating experience for
patients, frequently leading to post-
traumatic stress disorder [1]. In
studies conducted outside of the
UK, AWR has been estimated to
affect 1 to 2 per thousand surgical
patients [2–4]. If this incidence is
extrapolated to the UK, it would
suggest that thousands of surgical
patients a year could be experienc-
ing this complication. As such,
AWR is an important adverse event
for patients that requires the atten-
tion of healthcare practitioners and
policy makers. In a joint publication
in British Journal of Anaesthesia
and Anaesthesia [5, 6], Pandit and
colleagues report the results of the
first phase of the 5th National
Audit Project (NAP5) of the Royal
College of Anaesthetists in collabo-
ration with the Association of An-
aesthetists of Great Britain and
Ireland. The findings of the first
phase of NAP5 prompt a reconsid-
eration of the detection and inci-
dence of AWR.
The difficulty in detecting
awareness during an intended gen-
eral anaesthetic is manifest. Con-
scious experience is inherently
subjective, the neurobiology of con-
sciousness has yet to be elucidated,
and as such there is currently no
gold standard test for identifying
awareness. Despite the limitations,
studies that have sought to detect
awareness with evoked responsive-
ness as the outcome measure (e.g.
asking a patient at regular intervals
to squeeze an object and ensuring
that the hand holding the object is
not pharmacologically paralysed)
have found that about a third of
patients experience episodes of
awareness during intended general
anaesthesia [7]. Fortunately, there is
a low probability that these episodes
result in explicit memory formation.
Whether awareness without explicit
recall has any clinical relevance is a
matter of debate. It is therefore
appropriate that NAP5 focused on
AWR, a complication that clearly
precipitates patient distress and has
demonstrable clinical sequelae.
The National Audit Projects
seek to shed light on issues that are
important to patients and anaesthe-
tists alike. The overarching aim of
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NAP5 is to ascertain, over one full
year (1st June 2012 to 31st May
2013), how many patients in the
UK (and The Republic of Ireland,
where the audit will be running in
parallel) spontaneously report
AWR, and to elucidate relevant risk
factors for AWR (http://www.
nationalauditprojects.org.uk/NAP5_
Publications). The first or prelimin-
ary phase of the NAP5 endeavour,
which is reported by Pandit and
colleagues [5, 6], is a survey in
which anaesthetists around the UK
were asked about their practices
regarding the prevention of AWR
and their recollections of any AWR
reports that were brought to their
attention during 2011. This phase 1
NAP5 survey is impressive in its
scope and accomplishments; 100%
of contacted centres (329 hospitals)
participated, and a remarkable 82%
of senior anaesthetists (7125)
responded to the survey. Based on
cases of awareness that became
known to anaesthetists during 2011,
the survey suggests that the current
incidence of AWR in the UK is
about 1 in 15 000. This is much
lower than the 1 to 2 per 1000 inci-
dence that has been found in sev-
eral prospective studies that have
assessed AWR [2–4].
This is not the first time the field
of anaesthesia has been confronted
with an investigation reporting an
incidence of AWR one order of mag-
nitude lower than that found in pro-
spective studies. In 2007, Pollard and
colleagues described a study of AWR
in a regional medical system in the
US and found an incidence of
approximately 1 in 15 000, which is
commensurate with the findings of
the NAP5 survey [8]. This dramati-
cally lower incidence was attributed
either to differences in anaesthetic
technique or to the method of assess-
ing awareness. It will be beneficial to
consider the results of the NAP5 sur-
vey in light of these potential expla-
nations. First, the incidence of AWR
could be much lower in the UK than
has been reported previously in
other countries (i.e. ‘under the rate’).
Second, the NAP5 survey substan-
tially underestimated the incidence
of AWR (i.e. ‘under the radar’).
Third, both explanations may be
partially correct. It is unclear, based
on the design of NAP5, whether we
can adjudicate definitively among
these options.
If the incidence of AWR is
indeed lower in the UK than previ-
ously reported elsewhere, it is impor-
tant to consider why this might be in
order to reinforce good anaesthetic
techniques, and to inform practitio-
ners in other countries. The first and
most compelling explanation could
simply be that, unlike previous stud-
ies, the NAP5 survey is both national
and comprehensive. As such, all gen-
eral anaesthetics in all settings are
potentially captured, of which most
are probably low-risk outpatient sur-
gical procedures. A second reason
might be that the laryngeal mask air-
way and other supraglottic devices
have commonly been used during
general anaesthesia in the UK for
many years. When a supraglottic
device is used, neuromuscular block-
ing drugs are typically not adminis-
tered, and this would probably
mitigate both the incidence and the
severity of AWR 2, 9]. Surprisingly,
however, Sandin and colleagues
found an AWR incidence of 1 in
1000 even when neuromuscular
blocking drugs were not adminis-
tered [2]. A third factor might be
that the favourable staffing ratio and
extensive training of anaesthetists in
the UK are associated with increased
vigilance and decreased AWR. A
fourth possibility is that practitioners
have changed clinical behavior fol-
lowing studies suggesting that AWR
can be decreased with protocols
incorporating electroencephalogram
(EEG)-based monitors or end-tidal
anesthetic concentration (ETAC)
alerts [10–12]. The low utilization of
EEG-based monitors (only 1.8% rou-
tine use) among participant anaes-
thetists partially argues against the
EEG approach, but practitioners
might have set alerts based on low
ETAC thresholds. A fifth contributor
might be an avoidance of total intra-
venous anaesthesia (TIVA); the risk
of AWR is higher with TIVA than
with volatile-based anaesthesia [13–
15]. However, it is likely that TIVA
is more popular in the UK than in
the US. Therefore, low utilisation of
TIVA probably does not explain the
low practitioner-reported incidence
of AWR found in the NAP5 survey,
although the widespread use of tar-
get-controlled infusion pumps in the
UK might increase the safety of
TIVA (in relation to propofol under-
dosing).
In contrast to the hypothesised
reasons for a uniquely low inci-
dence of AWR in the UK, past
studies suggest that phase 1 of the
NAP5 project substantially under-
detected the true incidence of AWR
in the UK. It is important to
consider possible explanations for
this discrepancy in order to assist
interpretation of phase 2 of the
NAP5 project, which is designed to
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determine prospectively how many
patients report AWR in the UK.
The most important limitation of
NAP5 phase 1 is that AWR was
detected through intermediates (i.e.
senior anaesthetists) based on
patient self-reports rather than
through direct patient interviews. It
has been demonstrated that patients
are unlikely to report spontaneously
an AWR event to an anaesthetist
[16], perhaps because of the brief
interaction and limited relationship.
Based on data from a single hospi-
tal complex in the US, a retrospec-
tive audit of spontaneous patient
reports revealed a six-fold lower
incidence of AWR [17] than a
study in which patients were ques-
tioned directly [4]. Any study that
relies on spontaneous patient
reports of AWR rather than proac-
tive questioning of all patients is
likely to underestimate considerably
the incidence of AWR. Further-
more, in the phase 1 NAP5 practi-
tioner survey, as patients were not
questioned directly, it is self-evident
that patients were not asked specifi-
cally if they remembered anything
during the period of intended gen-
eral anaesthetic, which is one of the
questions in the modified Brice
interview [18]. Based on discrepant
findings between studies that have
asked this question [2, 3] and those
that haven’t [8], this targeted query
appears to be important. This argu-
ment is made even more compel-
ling by a study that compared the
detected incidence of awareness in a
single patient population through
two different methods: routine post-
operative interviews vs structured
questionnaires (i.e. modified Brice
interviews) that explicitly asked
patients whether they remembered
anything during the period in
which they were intended to be an-
aesthetised [19]. In this study, the
detected incidence was five times
higher when the explicit question
was asked [19]. As such, any study
that does not ask patients explicitly
about AWR is likely to underesti-
mate considerably the incidence of
AWR. Lastly, studies suggest that
patients might not remember or
might not choose to report that they
were aware immediately after their
surgery [2, 3, 12, 16]. One notable
case report described a patient who
chose not to disclose an AWR event
during two structured and explicit
interviews within a month of sur-
gery, but mentioned it spontane-
ously during a one-year follow-up
interview not related to detection of
AWR [20]. Patients should be inter-
viewed for AWR at least one to four
weeks after their surgery [2, 3, 12],
recognising that even this approach
will probably not capture all AWR
experiences.
In addition to the interesting
findings on AWR reports, the phase 1
NAP5 survey found a low use of
EEG-based monitors and a general
lack of policies to prevent and
manage AWR [5]. It is therefore
appropriate and encouraging that or-
ganisations representing anaesthetists
in the UK as well as the National
Institute for Health and Clinical
Excellence (NICE) are currently in
the process of addressing this policy
vacuum. Various quality improve-
ment measures or protocols are under
consideration for effectiveness and
efficiency, in addition to measures
that have previously been recom-
mended, such as the avoidance or
restricted administration of neuro-
muscular blocking drugs [9, 21, 22].
Evidence has accumulated over the
past few years that might be helpful
in framing clinical decision pathways
[23]. Practitioners should be encour-
aged to set alerts for a threshold low
ETAC when using a volatile-based
anaesthetic, as this practice probably
decreases AWR [4, 12, 24]. If neuro-
muscular blocking drugs are deemed
necessary, deliberation should be
given to using a volatile-based tech-
nique, as TIVA is associated with a
higher incidence of AWR [12–14]. If
TIVA is indicated or chosen (and
neuromuscular blocking drugs are
administered), a proprietary or non-
proprietary EEG-based monitor
should be used in order to decrease
the likelihood of AWR [11, 15]. The
recent NICE guidelines, issued in
November 2012, endorse the recom-
mendation that an EEG-based moni-
tor should be considered for patients
receiving TIVA. In addition, the
NICE guidelines recommend that
such monitors should be considered
for patients: i) assessed to be at higher
risk of AWR; ii) who are liable to
experience haemodynamic instability
at typical anaesthetic doses; or iii) for
whom there is a hypothetical concern,
owing to their perceived vulnerability,





worth noting that a non-proprietary
EEG can be used inexpensively.
Information from the EEG and from
non-proprietary processed EEG
336 © 2013 The Authors
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indices might yield comparable
information to commercially avail-
able devices [25–28].
Policy makers and practitioners
should not curtail their systematic
efforts to eradicate AWR based on the
first-phase NAP5 results, which could
be interpreted as pointing to the rarity
of AWR in the UK. As noted by Pan-
dit and colleagues, the methodology
of the NAP5 survey renders it vulner-
able to under-detection of AWR [5,
6]. Although both phases of NAP5
might ultimately provide substantial
underestimates of the true incidence
of AWR in the UK owing to their
reliance on spontaneous patient
reports, we nonetheless eagerly antici-
pate the next phase of NAP5, which
will provide a rich source of valuable
data as the first national and compre-
hensive prospective assessment of
AWR.
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Charting change on the labour ward
In this issue of Anaesthesia, Carle
et al. [1] have created a statistically
based template that they have used
to create an internally validated
warning score for the obstetric set-
ting. This marks the belated start to
a process that may produce a scien-
tifically derived universal obstetric
early warning score (EWS). If suc-
cessful, it will bring the obstetric
patient up to speed with the general
adult population.
I read the NEWS today
In 2007, the Royal College of Physi-
cians (RCP) issued the report Acute
Medical Care: the Right Person, in
the Right Setting – First Time [2].
This noted that a lack of standardi-
sation resulted in a variation of
methodology, approach and famil-
iarity with EWS, leading to a lack
of consistency in the response to
acute illness. In reaction, the RCP
commissioned the National Early
Warning Score Development and
Implementation Group (NEWS-
DIG) in 2009. This body met to
review the available evidence, con-
sider the existing models and devise
an observation chart, scoring system
and escalation pathway. This has
now been completed and in 2012,
the National Early Warning Score
NEWS [3] was implemented.
There has been no consensus
regarding the utility of EWS.
Indeed, a 2009 Cochrane review [4]
on outreach and EWS found only
two reliable randomised controlled
trials worldwide. One showed an
improvement for in-hospital mor-
tality but the other reported no sta-
tistical change at all. The review
concluded that “the lack of evidence
on outreach requires further multi-
site RCTs to determine potential
effectiveness”. Given that there is no
overwhelming evidence for their
efficacy, one would expect a degree
of reluctance from the medical fra-
ternity. However the uptake of
EWS continued, perhaps as a stick-
ing plaster for the reduction in
nursing contact with patients. As a
result, the use of EWS has been
inconsistently adopted throughout
developed healthcare systems. Con-
sequently, there are also many dif-
ferent models of the scoring system,
using many different observations
and many different parameters.
This makes it problematic to ascer-
tain exactly which aspects of the
scores are valuable. The fact that
NEWSDIG has homogenised EWS
charts to produce this system is
credit-worthy in itself.
NEWSDIG reviewed all existing
published literature and elected to
use an aggregate-weighted system.
These systems assign each observa-
tion with a score (usually 0–3). The
sum of all scores is taken and
the magnitude of this determines
the strength of the intervention
required. NEWSDIG devised its
score by utilising a review paper by
Smith et al. [5], that examined 33
different EWS systems already in
use. In addition, NEWSDIG sug-
gested that an extreme variation in
a single parameter should also trig-
ger a response and has thus incor-
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